DexCom Inc. (DXCM) News
Filter DXCM News Items
DXCM News Results
|Loading, please wait...|
DXCM News Highlights
- DXCM's 30 day story count now stands at 31.
- Over the past 27 days, the trend for DXCM's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
- CMS, AMP and ADD are the most mentioned tickers in articles about DXCM.
Latest DXCM News From Around the Web
Below are the latest news stories about DEXCOM INC that investors may wish to consider to help them evaluate DXCM as an investment opportunity.
The S&P 500 still faces its 200-day line with key economic data looming. Tesla rebounded from bear market lows while five medical stocks are near buy points.
SAN DIEGO, November 22, 2022--DexCom, Inc. (NASDAQ:DXCM) today announced that Matt Dolan, Executive Vice President, Strategy, Corporate Development and Dexcom Labs, will present an update on the company at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30am (EST).
Investors might want to consider buying stocks after the strong first half of the fourth quarter. Today, we explore three stocks that are set to expand within three crucial growth industries.
When it comes to selling short, there is one pattern that stands head and shoulders above the rest, in a manner of speaking.
While growth stocks aren't attracting the interest from investors that they were a few years ago, not all businesses that fall into this category of investments have dealt with the same headwinds as many former pandemic favorites. Today, we're going to take a look at two top healthcare stocks with growth-driven businesses that have a robust track record of rewarding investors. Intuitive Surgical (NASDAQ: ISRG) is a name known to many healthcare investors for its profitable and fast-growing surgical robotics business, which has led it to deliver a total return of about 345% to investors over the past decade.
Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches
EDINBURGH, Scotland, November 14, 2022--DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring, its global partners and Dexcom Warriors will once again help the world #SeeDiabetes and empower members of the diabetes community to express their unique journey with diabetes in an accessible way – by creating custom Dexcom CGM patches via the newly launched design site that illustrate just how unique each person’s diabetes story is.
No-brainer growth stocks to buy for 2023 and beyond are companies that are growing their top and bottom lines and piling up the cash.
Dexcom rallied higher on its third-quarter earnings and as it works to launch a new continuous glucose monitor in the U.S.
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...